LiveOnNY's Remarkable Achievement as a Top NYC Workplace
LiveOnNY Earns Recognition as a Top Workplace in NYC
LiveOnNY has achieved a significant milestone, earning the prestigious title of one of the best workplaces in New York City for the third year in a row. This accolade highlights LiveOnNY’s outstanding dedication to its employees and the mission to transform lives through organ and tissue donation.
A Thriving Organization Dedicated to Making a Difference
As the federally appointed organ procurement organization (OPO) for the New York City Metro area, LiveOnNY is at the forefront of life-saving efforts. The organization has seen remarkable growth and success, largely due to the implementation of a far-reaching strategic plan initiated by their newly appointed CEO, Leonard Achan. This plan aims not only to enhance operational efficiency but also to cultivate a culture of excellence within the organization.
Impressive Growth in Organ Donation Rates
Since launching this comprehensive strategy, LiveOnNY has reported a more than 50% increase in organ donation rates. This surge translates to the saving of thousands of lives, a true testament to the hard work and commitment of the LiveOnNY team. Their relentless efforts are aimed at addressing the urgent need for organ donations within the community.
Community Engagement and Outreach
In addition to boosting donation rates, LiveOnNY has prioritized community outreach, focusing on breaking down myths and educating the public about the importance of organ donation. Their initiatives resonate strongly with diverse communities, leading to over 60% of donors belonging to various racial and ethnic backgrounds, including Black, Asian, and Hispanic populations.
Embracing Diversity to Drive Success
LiveOnNY’s commitment to diversity extends beyond its donor base to its workforce as well. Approximately 60% of its staff and leadership come from diverse racial, cultural, and ethnic backgrounds, fostering a supportive work environment that values different perspectives. This diverse representation fuels creativity and innovation, both crucial for the ongoing success of the organization.
A Focus on Employee Satisfaction
The recognition from Crain’s Best Places to Work is not just a reflection of LiveOnNY’s operational success but also of its workplace culture. The organization believes that its employees are the backbone of its mission. This award is a direct result of their ongoing commitment to employee satisfaction, well-being, and professional growth.
Leonard Achan, the President and CEO of LiveOnNY, stated, "We are honored to receive this accolade for the third consecutive year. The remarkable dedication of our employees and the selflessness of our donor heroes play a significant role in our success as a leading OPO. Every day, we strive to honor the lives we touch and the communities we serve."
Transparency and Recognition
The final determination of the best places to work is grounded in an anonymous employee survey conducted by a third party, focusing on employee experiences and attitudes towards their workplace environment. This award speaks volumes about the culture and dedication of LiveOnNY’s staff.
The results of this ranking will be published in the upcoming October print issue of Crain’s New York.
About LiveOnNY
LiveOnNY is a nonprofit organization dedicated to saving lives through organ, eye, and tissue donation. Established in 1978, it serves a diverse population in the New York City area. LiveOnNY works closely with hospitals and transplant centers to facilitate the donation process, but its commitment goes beyond that. They actively promote public education around organ donation to increase awareness and encourage individuals to make the life-saving decision to register as donors.
LiveOnNY is a proud member of the United Network for Organ Sharing (UNOS), the organization overseeing the national organ transplant waiting list. With a mission to enhance lives while transforming tragedies into hope, LiveOnNY remains focused on serving both their community and the heroes who choose to donate.
Frequently Asked Questions
What recognition has LiveOnNY received recently?
LiveOnNY was named a Crain's Best Place to Work in NYC for the third consecutive year, highlighting its excellent workplace culture.
How has LiveOnNY improved organ donation rates?
By implementing a strategic plan, LiveOnNY increased organ donations by over 50%, saving thousands of lives.
What initiatives does LiveOnNY have for community engagement?
LiveOnNY focuses on educating the public about organ donation and breaking down myths to encourage diverse participation.
What is the workforce diversity at LiveOnNY?
About 60% of LiveOnNY’s staff and leadership represent diverse backgrounds, fostering an inclusive culture.
How is employee satisfaction measured at LiveOnNY?
Crain's conducts anonymous surveys to gauge employee experiences, which contributed to LiveOnNY’s recognition as a top workplace.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- South Korea's Export Growth Forecast: Trends and Insights
- OKX Wallet Unveils Innovative Tool for SOL Account Management
- Molecular Partners Set to Present Groundbreaking Cancer Therapy
- Tornator Secures Major Financial Backing with New Loans
- Investors of Equity LifeStyle Properties Should Act Now
- Copenhagen's Green Tourism Initiative: A Shift for Sustainability
- Copenhagen's Bold Tourism Strategy for a Sustainable Future
- Investor Participation Urged in Verve Therapeutics Case
- Legal Action for Investors of WEBTOON Entertainment Ltd.
- China's Market Rally Sparks Global Economic Optimism
Recent Articles
- Genpact Earns Top Honors in Global Company Rankings
- FedEx Struggles with Earnings Miss, Shares Show Resilience
- Celebrating Motherhood: Momcozy's Impact at NYFW Brand Day
- Join PG&E for an Innovative Exploration of Energy’s Future
- Morgan Herbert William's $15K Investment in Private Shares Fund
- American Textile Company Celebrates Recent Award Recognition
- THG's Earnings Call Reveals Strategic Progress and Future Plans
- Ensurge Micropower Secures NOK 75 Million Through New Shares
- Millicom Leadership Transition: A New Era Begins with Lombardini
- MongoDB Director Shares Insights Following Recent Stock Sale
- Empowering Young Minds: A Focus on Water Conservation Education
- MongoDB Executive Share Transactions Highlight Growth Potential
- Zenas BioPharma Surpasses Expectations in IPO Success
- Paylocity Insider Transaction Highlights Financial Growth Prospects
- Ensurge Micropower ASA's Upcoming Financial Opportunities
- Atlassian CEO Sells Stock Amidst Positive Company Trends
- authID's Recent Grant of Stock Options Boosts Employee Engagement
- FedEx Experiences Decline in First Quarter Earnings Due to Demand
- YHN Acquisition I Limited Successfully Closes $60 Million IPO
- Atlassian's Scott Farquhar Moves Shares: Key Financial Insights
- Altamira Therapeutics Successful Completion of $12 Million Offering
- Impacts of the Fed's Rate Cut on Global Financial Markets
- Alliance Entertainment Achieves Notable Growth and Profitability
- ValOre Metals Unlocks Potential with New CAD $3.5 Million Placement
- Tectonic Therapeutics Reports Positive TX45 Phase 1a Results
- Arq, Inc. Unveils Exciting New Public Stock Offering Plans
- Credit Acceptance Boosts Financing Capacity with New Terms
- Macy’s, Inc. Seeking to Fill Over 31,500 Seasonal Roles
- 89bio Provides Stock Options to New Employee Amid Growth Stage
- Preferred Bank Declares Cash Dividend and Business Highlights
- TechnipFMC Secures Major Subsea Contracts for Brazilian Reserves
- Globavend Holdings Reports Impressive Growth in H1 2024
- Market Reactions to Fed Rate Cut: Impacts and Insights
- Life Sciences BC Welcomes New Board Members and Leaders
- iPower Inc. Achieves Record Financial Performance in 2024
- Endava plc Class Action Lawsuit - Protect Your Investments
- Class Action Alert: WEBTOON Entertainment Inc. Investors Unite!
- Celsius Holdings Welcomes Hans Melotte to Board of Directors
- Rezolute's Promising Financial Year and Ersodetug Developments
- Major Class Action Lawsuit Against Extreme Networks, Inc. Investors
- MEI Pharma Discusses Strategic Alternatives and Cash Flow
- Investors of Symbotic, Inc. Have Opportunity to Join Lawsuit
- Casella Waste Systems Wraps Up Successful Offering of Stock
- FedEx Unveils Solid Q1 Earnings, Growth Strategies Ahead
- Arq, Inc. Pursues Growth with Public Offering of Stock
- Innovative Partnership Aims to Enhance Remote Patient Monitoring
- First Trust Intermediate Duration Fund Announces Monthly Dividend
- LPL Financial Surges in August 2024 With New Growth Metrics
- Duff & Phelps Utility Fund Announces Upcoming Dividends
- Altamira Therapeutics Secures $12 Million in Public Offering